Formation and characterization of chitosan-polylacticacid-polyethylene glycol-gelatin nanoparticles: A novel biosystem for controlled drug delivery

Carbohydrate Polymers

Volumn 98, Issue 1, 2013, Pages 951-958

  Rajan, M ^a   Raj, V ^a  

^a PERIYAR UNIVERSITY   (India)

Author keywords

Chitosan; Drug delivery; Encapsulation; Gelatin; Nanoparticles; Polyethylene glycol; Rifampicin

Indexed keywords

CHITIN; CHITOSAN; CROSSLINKING; DRUG DELIVERY; EMULSIFICATION; ENCAPSULATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYETHYLENES; SCANNING ELECTRON MICROSCOPY;

ANTI-BACTERIAL ACTIVITY; BIOCHEMICAL ACTIVITY; CONTROLLED DELIVERY; EMULSION SOLVENT EVAPORATION; GELATIN; GELATIN NANOPARTICLES; POLARIZING MICROSCOPES; RIFAMPICIN;

CONTROLLED DRUG DELIVERY;

MYCOBACTERIUM;

CHITOSAN; DRUG CARRIER; GELATIN; LACTIC ACID; MACROGOL; MACROGOL DERIVATIVE; NANOPARTICLE; POLYLACTIC ACID; POLYMER; RIFAMPICIN; SOLVENT;

ARTICLE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; ENCAPSULATION; MYCOBACTERIUM SMEGMATIS; PARTICLE SIZE; VOLATILIZATION;

CHITOSAN; DRUG DELIVERY; ENCAPSULATION; GELATIN; NANOPARTICLES; POLYETHYLENE GLYCOL; RIFAMPICIN;

CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; GELATIN; LACTIC ACID; MYCOBACTERIUM SMEGMATIS; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYMERS; RIFAMPIN; SOLVENTS; VOLATILIZATION;

EID: 84885146381     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2013.05.025     Document Type: Article

References (37)

1. Ashish Dev, Binulal, N. S., Anitha, A., Nair, S. V., Furuike, T., Tamura, H., et al. (2010). Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications. Carbohydrate Polymers, 80, 833-838.
2. Booysen, L. L., Kalombo, L., Brooks, E., Hansen, R., Gilliland, J., Gruppo, V., et al. (2013). In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid. International Journal of Pharmaceutics, 444(2013), 10-17.
3. Centers for Disease Control. (2000). Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recommendations and Reports, 49, 1-51.
4. Chan, J., Chan, H., Prestidge, C., Denman, J., Young, P., & Traini, D. (2013). A novel dry powder inhalable formulation incorporating three first-line antitubercular antibiotics. European Journal of Pharmaceutics and Biopharmaceutics, 83, 285-292.
5. Changsan, N., Chan, H. K., Separovic, F., & Srichana, T. (2009). Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation. Journal of Pharmaceutical Sciences, 98, 628-639.
6. Chen, H. L., Yang, W. Z., Chen, H., Liu, L. R., Gao, F. P., Yang, X. D., et al. (2009). Surface modification of mitoxantrone-loaded PLGA nanospheres with chitosan. Colloids and Surface B: Biointerfaces, 73, 212-218.
7. Chen, M., Liu, Y., Yang, W., Li, X., Liu, L., Zhou, Z., et al. (2011). Preparation and characterization of self-assembled nanoparticles of 6-O-cholesterol-modified chitosan for drug delivery. Carbohydrate Polymers, 84, 1244-1251.
8. Coban, A. Y., Birinci, A., Ekinci, B., & Durupinar, B. (2004). Drug susceptibility testing of Mycobacterium tuberculosis by the broth microdilution method with 7H9 broth. Memorias do Instituto Oswaldo Cruz, 99, 111-113. (Pubitemid 38406275)
9. Desai, K. G. H., & Park, H. J. (2005). Preparation and characterization of drug-loaded chitosan-tripolyphosphate microspheres by spray drying. Drug Development Research, 64, 114-128. (Pubitemid 40756865)
10. Du Toit, L. C., Pillay, V., & Danckwerts, M. P. (2006). Tuberculosis chemotherapy: Current drug delivery approaches. Respiratory Research, 19(7), 118.
11. Geng, L., Yonglong, Z., Qing, M., Mozhen, W., & Yuee, F. (2008). Preparation characterization and aggregation behavior of amphiphilic chitosan derivative having poly (l-lactic acid) side chains. Carbohydrate Polymer, 72, 60-66.
12. Gumbo, T., Louie, A., Deziel, M. R., Liu, W., Parsons, L. M., & Salfinger, M. (2007). Concentration dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin. Antimicrobial Agents and Chemotherapy, 51, 3781.
13. He, D., Deng, P., Yang, L., Tan, Q., Liu, J., Yang, M., et al. (2013). Molecular encapsulation of rifampicin as an inclusion complex of hydroxypropyl-cyclodextrin: Design; characterization and in vitro dissolution. Colloids and Surfaces B: Biointerfaces, 103, 580-585.
14. Hillmyer, M. A. (2007). Micelles made to order (A perspective). Science, 317, 604.
15. Hirota, K., Hasegawa, T., Hinata, H., Ito, F., Inagawa, H., Kochi, C., et al. (2007). Optimum conditions for efficient phagocytosis of rifampicin loaded PLGA microspheres by alveolar macrophages. Journal of Controlled Release, 119, 69-76. (Pubitemid 46561547)
16. Hirota, K., Hasegawa, T., Nakajima, T., Inagawa, H., Kohchi, C., Soma, G., et al. (2010). Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis. Journal of Controlled Release, 142, 339-346.
17. Huwyler, J., Wu, D., & Pardridge, W. M. (1996). Brain drug delivery of small molecules using immunoliposomes. Proceedings of the National Academy of Sciences of the United States of America, 93, 14164-14169. (Pubitemid 26424263)
18. Jayakumar, R., Reis, R. L., & Mano, J. F. (2006). Phosphorous containing chitosan beads for controlled oral drug delivery. Journal of Bioactive and Compatible Polymers, 21(4), 327-340. (Pubitemid 43958793)
19. Jelvehgari, M., Nokhodchi, A., Rezapour, M., & Valizadeh, H. (2010). Effect of formulation and processing variables on the characteristics of tolmetin microspheres prepared by double emulsion solvent diffusion method. Indian Journal of Pharmaceutical Sciences, 72, 72-78.
20. Klaudt, K. (2000). The political causes and solutions of the current tuberculosis epidemic. In J. Whitman (Ed.), The politics of emerging and resurgent infectious diseases. London: MacMillan Press.
21. Kweon, D. K., & Kang, D. W. (1999). Drug-release behavior of chitosan-g-poly(vinyl alcohol) copolymer matrix. Journal of Applied Polymer Science, 74, 458-464. (Pubitemid 129659134)
22. Langer, R. (2001). Perspectives: Drug delivery - Drugs on target. Science, 293, 58.
23. Mehta, S. K., & Jindal, N. (2013). Formulation of tyloxapol niosomes for encapsulation stabilization and dissolution of anti-tubercular drugs. Colloids and Surfaces B: Biointerfaces, 101, 434-441.
24. Mehta, S. K., Bhasin, K. K., Mehta, N., & Dham, S. (2005). Behavior of rifampicin in association with cylodextrin in aqueous media: A spectroscopic and conductometric study. Colloid and Polymer Science, 283, 532.
25. Papadimitriou, S., Bikiaris, D., Avgoustakis, K., Karavas, E., & Georgarakis, M. (2008). Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydrate Polymers, 73, 44-54.
26. Rahul, M. R., Amol, V. J., & Douglas, E. H. (2010). Poly(lactic acid) modifications. Progress in Polymer Science, 35, 338.
27. Rajan, M., & Raj, V. (2012). Encapsulation characterisation and in-vitro release of anti-tuberculosis drug using chitosan-poly ethylene glycol nanoparticles. International Journal of Pharmacy and Pharmaceutical Sciences, 4, 255-259.
28. Rashidova, S. Sh., Milusheva, R. Yu., Semenova, L. N., Mukhamedjanova, M. Yu., Voropaeva, N. L., Vasilyeva, S., et al. (2004). Characteristics of interactions in the pectin-chitosan system. Chromatographia, 59, 779-782. (Pubitemid 38888029)
29. Schreiber, J., Zissel, G., Greinert, U., Schlaak, M., & Muller-Quernheim, J. (1999). Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs. European Journal of Medical Research, 4, 67.
30. Singh, H., Bhandari, R., & Indu Pal, K. (2013). Encapsulation of rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with isoniazid at acidic pH. International Journal of Pharmaceutics, 446, 106-111.
31. Sullivan, S. M., & Huang, L. (1986). Enhanced delivery to target cells by heat-sensitive immunoliposomes. Proceedings of the National Academy of Sciences of the United States of America, 83, 6117.
32. (2013). International Union Against Tuberculosis and Lung Disease. The Union.
33. Tzong-Ming, W., & Cheng-Yang, W. (2006). Crystallization and melting behavior of poly(caprolactone) under physical confinement. Polymer Degradation and Stability, 91, 2198.
34. Wu, J., Kong, T., Yeung, K. W. K., Shum, H. C., Cheung, K. M. C., Wang, L., et al. (2013). Fabrication and characterization of monodisperse PLGA-alginate core-shell microspheres with monodisperse size and homogeneous shells for controlled drug release. Acta Biomaterialia, http://dx.doi.org/10. 1016/j.actbio.2013.03.022
35. Yan, S., Changsheng, L., Yuan, Y., Xinyi, T., Fan, Y., & Xiaoqian, S. (2009). Longcirculating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. Biomaterials, 30(12), 2340-2348.
36. Yang, X. D., Zhang, Q. Q., Wang, Y. S., Chen, H., Zhang, H. Z., & Gao, F. P. (2008). Self-aggregated nanoparticles from methoxy poly(ethylene glycol)-modified chitosan: Synthesis; characterization; aggregation and methotrexate release in vitro. Colloids and Surface B: Biointerfaces, 61, 125-131.
37. Zhang, H. Z., Gao, F. P., Liu, L. R., Li, X. M., Zhou, Z. M., & Yang, X. D. (2009). Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy. Colloids and Surface B: Biointerfaces, 71, 19-26.